文献速递眼底病与葡萄膜炎

血管紧张素II/AT1受体信号在调节视网膜小胶质细胞活化中的作用

The Role of Angiotensin II/AT1 Receptor Signaling in Regulating Retinal Microglial Activation.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

研究在成年Cx3Cr1+/GFP小鼠视网膜铺片上观察血管紧张素II(AngII)对小胶质细胞活化的直接影响。AngII灌注使突起长度立即改变(-42%,P < 0.05),AT1受体阻断可改善;玻璃体内注射AngII 24小时后小胶质细胞活化,胞体增大(23%,P < 0.001)、突起缩短(20%,P < 0.05),与神经元接触减少(生理盐水15.6 ± 2.31 vs AngII 7.8 ± 1.06,P < 0.05)。作者认为AngII可能通过小胶质细胞上的AT1受体直接活化小胶质细胞并参与视网膜炎症。

要点

  • 视网膜小胶质细胞表达AT1受体。
  • AngII灌注使小胶质细胞突起长度立即改变(-42%,P < 0.05),AT1受体阻断可改善。
  • 玻璃体内注射AngII 24小时后小胶质细胞活化,胞体增大(23%,P < 0.001)、突起缩短(20%,P < 0.05)。

核心结论

  • 视网膜小胶质细胞表达AT1受体,其活化状态被促血管生成因子AngII显著改变。
  • AngII可能通过小胶质细胞上的AT1受体直接活化小胶质细胞并参与视网膜炎症。
  • 这可能对糖尿病视网膜病变等AngII升高和炎症起重要作用的疾病有意义。

研究设计与样本

  • 研究在成年Cx3Cr1+/GFP小鼠的活体视网膜铺片上观察小胶质细胞动态活动,条件为对照、AngII(5 μM)或AngII(5 μM)+坎地沙坦(0.227 μM)。
  • 研究还观察了玻璃体内注射AngII(10 mM)24小时后的效应,视网膜用于免疫细胞化学、流式细胞术或炎症定量PCR阵列。

主要发现

  • FACS分离的视网膜小胶质细胞表达AT1受体。
  • 对照条件下小胶质细胞突起呈特征性运动,AngII灌注使突起长度立即改变(-42%,P < 0.05)并改变活化状态,AT1受体阻断可改善。
  • 玻璃体内注射AngII 24小时后小胶质细胞活化,胞体增大(23%,P < 0.001)、突起缩短(20%,P < 0.05)。
  • 小胶质细胞与视网膜神经元接触数显著减少(生理盐水15.6 ± 2.31 vs AngII 7.8 ± 1.06,P < 0.05)。
  • 视网膜细胞因子和趋化因子表达受到调节,提示炎症性视网膜表型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study explored whether the proangiogenic factor Angiotensin II (AngII) had a direct effect on the activation state of microglia via the Angiotensin type 1 receptor (AT1-R). METHODS: Microglial dynamic activity was investigated in live retinal flatmounts from adult Cx3Cr1+/GFP mice under control, AngII (5 μM) or AngII (5 μM) + candesartan (0.227 μM) conditions. The effects of intravitreal administration of AngII (10 mM) were also investigated at 24 hours, with retinae processed for immunocytochemistry, flow cytometry, or inflammatory quantitative PCR arrays. RESULTS: We found FACS isolated retinal microglia expressed AT1-R. In retinal flatmounts, microglia showed characteristic movement of processes under control conditions. Perfusion of AngII induced an immediate change in process length (-42%, P < 0.05) and activation state of microglia that was ameliorated by AT1-R blockade, suggesting a direct effect of AngII on microglia via the AT1-R. Intravitreal injection of AngII induced microglial activation after 24 hours, which was characterized by increased soma size (23%, P < 0.001) and decreased process length (20%, P < 0.05). Further analysis indicated a significant decrease in the number of microglial contacts with retinal neurons (saline 15.6 ± 2.31 versus AngII 7.8 ± 1.06, P < 0.05). Retinal cytokine and chemokine expression was modulated, indicative of an inflammatory retinal phenotype. CONCLUSIONS: We show that retinal microglia express AT1-R and their activation state is significantly altered by the angiogenic factor, AngII. Specifically, AngII may directly activate AT1-Rs on microglia and contribute to retinal inflammation. This may have implications for diseases like diabetic retinopathy where increases in AngII and inflammation have been shown to play an important role.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Phipps JA, Vessey KA, Brandli A, et al. The Role of Angiotensin II/AT1 Receptor Signaling in Regulating Retinal Microglial Activation. Invest Ophthalmol Vis Sci. 2018. PMID: 29368003. doi:10.1167/iovs.17-22416

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。